FDA Accepts New Drug Application for Shorla Oncology's Novel Treatment for Breast, Ovarian Cancer

SH-105 eliminates the need for powder reconstitution, which Shorla stated will bolster the novel product’s efficiency and lower the risks associated with drug preparation.

Source link
#FDA #Accepts #Drug #Application #Shorla #Oncology039s #Treatment #Breast #Ovarian #Cancer